In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biohaven Pharmaceutical Holding Co. Ltd.

www.biohavenpharma.com

Latest From Biohaven Pharmaceutical Holding Co. Ltd.

Biohaven Taking Troriluzole Into Phase III OCD Study Despite Phase II/III Miss

After a prior failure in treating anxiety, the company believes the glutamate modulator showed signs of efficacy in obsessive-compulsive disorder that are worth pursuing, including at a higher dose.

Clinical Trials Neurology

Royalty Pharma Nears Biopharma Record Take With $2.18bn IPO

Company specializing in trading upfront cash for downstream earnings makes its public debut with largest IPO of 2020, and the second largest ever in biopharma.

Financing Business Strategies

Commercial Models Shifting As Pharma Mulls Digital-First Launches

Pharma is assessing digital-first launch strategies amid COVID-19 while a resizing of sales forces and the emergence of "digital orchestrators" may also be in store, the co-founder of healthcare solutions provider Indegene tells Scrip.

Commercial Strategy

Keeping Track: Approvals For Phexxi, Kynombi; New Claims For Lynparza, Alunbrig, Tecentriq; Intercept May Miss NASH User Fee Date

The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.

US FDA Performance Tracker Approvals
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Biohaven Pharmaceuticals
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Biohaven Pharmaceutical Holding Co. Ltd.
  • Senior Management
  • Vlad Coric, MD, CEO
    Jim Engelhart, CFO
    Robert Berman, MD, CMO
    John Tilton, Chief Commercial Officer
    Charlie Conway, PhD, CSO
    Elyse Stock, MD, Chief, Portfolio Strategy & Dev.
    Donnie McGrath, MD, Chief, Corp. Strategy & Bus. Dev.
    Kim Gentile, VP, Operations
  • Contact Info
  • Biohaven Pharmaceutical Holding Co. Ltd.
    Phone: (203) 404-0410
    234 Church St.
    New Haven, CT 06510
    USA
UsernamePublicRestriction

Register